Puzo Michael J Sells 2,745 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Puzo Michael J decreased its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 10.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,225 shares of the company’s stock after selling 2,745 shares during the quarter. Puzo Michael J’s holdings in Roche were worth $845,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. HighPoint Advisor Group LLC boosted its stake in Roche by 2.8% in the fourth quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after buying an additional 304 shares in the last quarter. Hantz Financial Services Inc. grew its holdings in shares of Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares during the last quarter. Brooklyn Investment Group increased its position in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after purchasing an additional 363 shares in the last quarter. Altrius Capital Management Inc lifted its stake in Roche by 0.3% in the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after purchasing an additional 603 shares during the last quarter. Finally, Diversified Trust Co grew its stake in shares of Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after buying an additional 711 shares during the last quarter.

Roche Trading Up 1.7 %

Shares of RHHBY stock opened at $40.02 on Friday. The stock has a 50-day moving average of $41.41 and a 200-day moving average of $38.73. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $44.31.

Analyst Ratings Changes

Several equities research analysts recently weighed in on RHHBY shares. Morgan Stanley initiated coverage on Roche in a report on Wednesday, February 12th. They set an “equal weight” rating on the stock. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a report on Thursday, January 30th. Finally, UBS Group raised shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.